148 related articles for article (PubMed ID: 17510599)
21. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
Givertz MM; Andreou C; Conrad CH; Colucci WS
Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
[TBL] [Abstract][Full Text] [Related]
22. Inotropic, vasodilating and preconditioning actions of levosimendan in the heart.
Meyer K; Schipke JD; Klocke RC; Gams E; Korbmacher B
Thorac Cardiovasc Surg; 2008 Oct; 56(7):379-85. PubMed ID: 18810693
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
Banfor PN; Preusser LC; Campbell TJ; Marsh KC; Polakowski JS; Reinhart GA; Cox BF; Fryer RM
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006
[TBL] [Abstract][Full Text] [Related]
24. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
[TBL] [Abstract][Full Text] [Related]
25. No beneficial effects of levosimendan in acute porcine endotoxaemia.
Chew MS; Hawthorne WJ; Bendall J; Whereat S; Huang S; Ting I; Simond D; McLean A
Acta Anaesthesiol Scand; 2011 Aug; 55(7):851-61. PubMed ID: 21574964
[TBL] [Abstract][Full Text] [Related]
26. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
Rokyta R; Pechman V
Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
[TBL] [Abstract][Full Text] [Related]
27. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
Morelli A; De Castro S; Teboul JL; Singer M; Rocco M; Conti G; De Luca L; Di Angelantonio E; Orecchioni A; Pandian NG; Pietropaoli P
Intensive Care Med; 2005 May; 31(5):638-44. PubMed ID: 15812624
[TBL] [Abstract][Full Text] [Related]
28. Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model.
Wiklund A; Kylhammar D; Rådegran G
J Cardiovasc Pharmacol; 2012 May; 59(5):441-9. PubMed ID: 22240915
[TBL] [Abstract][Full Text] [Related]
29. Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study.
Dubin A; Murias G; Sottile JP; Pozo MO; Barán M; Edul VS; Canales HS; Etcheverry G; Maskin B; Estenssoro E
Intensive Care Med; 2007 Mar; 33(3):485-94. PubMed ID: 17262190
[TBL] [Abstract][Full Text] [Related]
30. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure.
Kerbaul F; Gariboldi V; Giorgi R; Mekkaoui C; Guieu R; Fesler P; Gouin F; Brimioulle S; Collart F
Crit Care Med; 2007 Aug; 35(8):1948-54. PubMed ID: 17568324
[TBL] [Abstract][Full Text] [Related]
31. Levosimendan in aortic valve surgery: cardiac performance and recovery.
Järvelä K; Maaranen P; Sisto T; Ruokonen E
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):693-8. PubMed ID: 18922425
[TBL] [Abstract][Full Text] [Related]
32. Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock.
García-Septien J; Lorente JA; Delgado MA; de Paula M; Nin N; Moscoso A; Sánchez-Ferrer A; Perez-Vizcaino F; Esteban A
Shock; 2010 Sep; 34(3):275-80. PubMed ID: 19997054
[TBL] [Abstract][Full Text] [Related]
33. Effects of levosimendan on hemodynamics, local cerebral blood flow, neuronal injury, and neuroinflammation after asphyctic cardiac arrest in rats.
Kelm RF; Wagenführer J; Bauer H; Schmidtmann I; Engelhard K; Noppens RR
Crit Care Med; 2014 Jun; 42(6):e410-9. PubMed ID: 24633188
[TBL] [Abstract][Full Text] [Related]
34. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.
De Luca L; Proietti P; Celotto A; Bucciarelli-Ducci C; Benedetti G; Di Roma A; Sardella G; Genuini I; Fedele F
Am Heart J; 2005 Sep; 150(3):563-8. PubMed ID: 16169341
[TBL] [Abstract][Full Text] [Related]
35. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction.
Missant C; Rex S; Segers P; Wouters PF
Crit Care Med; 2007 Mar; 35(3):707-15. PubMed ID: 17255859
[TBL] [Abstract][Full Text] [Related]
36. Myocardial efficiency during calcium sensitization with levosimendan: a noninvasive study with positron emission tomography and echocardiography in healthy volunteers.
Ukkonen H; Saraste M; Akkila J; Knuuti MJ; Lehikoinen P; Någren K; Lehtonen L; Voipio-Pulkki LM
Clin Pharmacol Ther; 1997 May; 61(5):596-607. PubMed ID: 9164421
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of myocardial function and reduction of injury with levosimendan after percutaneous coronary intervention for acute myocardial infarction: a pilot study.
Wu X; Wu J; Yan X; Zhang Y
Cardiology; 2014; 128(2):202-8. PubMed ID: 24751502
[TBL] [Abstract][Full Text] [Related]
38. Septic cardiomyopathy in rat LPS-induced endotoxemia: relative contribution of cellular diastolic Ca(2+) removal pathways, myofibrillar biomechanics properties and action of the cardiotonic drug levosimendan.
Wagner S; Schürmann S; Hein S; Schüttler J; Friedrich O
Basic Res Cardiol; 2015 Sep; 110(5):507. PubMed ID: 26243667
[TBL] [Abstract][Full Text] [Related]
39. Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction.
Lilleberg J; Sundberg S; Nieminen MS
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S63-9. PubMed ID: 8907133
[TBL] [Abstract][Full Text] [Related]
40. The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts.
Behrends M; Peters J
Intensive Care Med; 2003 Oct; 29(10):1802-7. PubMed ID: 12879240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
